Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Mabron
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mabron 100mg modified-release tablets (Teva)
040702040BHADAC
|
Mabron | Tramadol hydrochloride | Central Nervous System | 155 |
|
Mabron 150mg modified-release tablets (Teva)
040702040BHAEAD
|
Mabron | Tramadol hydrochloride | Central Nervous System | 33 |
|
Mabron 100mg modified-release tablets (Morningside)
040702040BHAAAC
|
Mabron | Tramadol hydrochloride | Central Nervous System | 29 |
|
Mabron 200mg modified-release tablets (Teva)
040702040BHAFAE
|
Mabron | Tramadol hydrochloride | Central Nervous System | 29 |
|
Mabron 200mg modified-release tablets (Morningside)
040702040BHACAE
|
Mabron | Tramadol hydrochloride | Central Nervous System | 12 |
|
Mabron 150mg modified-release tablets (Morningside)
040702040BHABAD
|
Mabron | Tramadol hydrochloride | Central Nervous System | 2 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.